Neochem Bio Solutions Financial Statements
Neochem Bio Solutions financial statements. In FYNone, Neochem Bio Solutions (NEOCHEM) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 9.3% and ROE of 40.0%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read Neochem Bio Solutions dividend policy for the complete payout history and dividend yield track record.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEOCHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEOCHEM YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Analyse NEOCHEM shareholding pattern to track promoter, FII and institutional holdings.
NEOCHEM Income Statement — Revenue, EBITDA & Net Profit
Neochem Bio Solutions revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 9.3%. For live price, earnings ratios and company overview, see NEOCHEM share price screener.
| Particulars | None | March 2025 | March 2024 |
|---|---|---|---|
| Revenue | 0 | 86 | 62 |
| Expenses | 0 | 71 | 55 |
| EBITDA | 0 | 15 | 7 |
| Operating Profit Margin % | 0.00% | 16.00% | 10.00% |
| Depreciation | 0 | 1 | 1 |
| Interest | 0 | 4 | 3 |
| Profit Before Tax | 0 | 10 | 3 |
| Tax | 0 | 3 | 1 |
| Net Profit | 0 | 8 | 2 |
| Earnings Per Share (₹) | 0.00 | 6.64 | 1.90 |
NEOCHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEOCHEM total assets ₹79 Cr, total equity ₹20 Cr, total liabilities ₹ Cr (2025) — ROE 40.0%.
| Particulars | 2025 | 2024 |
|---|---|---|
| ASSETS | ||
| Total Assets | 79 | 64 |
| Current Assets | 53 | 39 |
| Fixed Assets | 19 | 19 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 60 | 45 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 15 | 19 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 20 | 12 |
| Share Capital | 7 | 7 |
| Reserves & Surplus | 13 | 5 |
NEOCHEM Cash Flow Statement — Operating, Investing & Financing
Neochem Bio Solutions operating cash flow ₹3 Cr, investing ₹-2 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 3 | 2 | -1 |
| Investing Activities | -2 | -8 | -3 |
| Financing Activities | -1 | 6 | 4 |
| Net Cash Flow | 0 | 0 | 0 |